Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer

Author： Miller Lesley-Ann N Roy Anuja Mody Reema Higa Gerald M

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.8, Iss.11, 2007-08, pp. : 1675-1691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3476-3487

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers

By Smith H.J. Nicholls P.J. Simons C. Lain R.L.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 789-824

Informa Healthcare

Access to resources Recommend Favorite

Tamoxifen Resistant and Refractory Breast Cancer: The Value of Aromatase Inhibitors

By Goss P.E.

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 957-966

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer

By Bajetta E.

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 271-283

Adis International

Access to resources Recommend Favorite

Aromatase inhibitors of value in breast cancer treatment

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite